Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging

Archive ouverte

Pagès, Mélanie | Pajtler, Kristian | Puget, Stéphanie | Castel, David | Boddaert, Nathalie | Tauziède-Espariat, Arnault | Picot, Stéphanie | Debily, Marie‐anne | Kool, Marcel | Capper, David | Sainte-Rose, Christian | Chrétien, Fabrice | Pfister, Stefan | Pietsch, Torsten | Grill, Jacques | Varlet, Pascale | Andreiuolo, Felipe

Edité par CCSD ; Wiley -

International audience. Ependymoma with RELA fusion has been defined as a novel entity of the revised World Health Organization 2016 classification of tumors of the central nervous system (CNS), characterized by fusion transcripts of the RELA gene and consequent pathological activation of the NFkB pathway. These tumors represent the majority of supratentorial ependymomas in children. The validation of diagnostic tools to identify this clinically relevant ependymoma entity is essential. Here, we have used interphase fluorescent in situ hybridization (FISH) for C11orf95 and RELA , immunohistochemistry (IHC) for p65‐RelA and the recently developed DNA methylation‐based classification besides conventional histopathology, and compared the precision of the methods in 40 supratentorial pediatric brain tumors diagnosed as ependymomas in the past years. Reverse transcription PCR (RT‐PCR) and RNA sequencing were performed to explore discordant cases. Furthermore, we integrated imaging and clinical features as additional layers of information. The concordance between nuclear RelA expression by IHC and RELA FISH was 100%. Concordance between IHC and DNA methylation profiling, and between FISH and DNA methylation profiling was also high (96.4% and 95.2%, respectively). Thirty‐four out of 40 (85%) cases were confirmed by integrated diagnoses as ependymal tumors, including 22 RELA ‐fused ependymomas (71% of ependymal tumors), two YAP1‐ fused ependymomas (6%), six non‐ RELA /non‐ YAP1 ependymomas (18%) and four ependymal/subependymal mixed tumors (12%). Ependymal/subependymal mixed tumors had an excellent clinical outcome despite the presence of histopathological signs of malignancy, suggesting that these tumors should not be diagnosed as classic ependymomas. DNA methylation profiling helped in the differential diagnosis of RELA‐ fused ependymomas. IHC and FISH, which are available in the majority of pathology laboratories, are valuable tools to identify RELA ‐fused ependymomas.

Suggestions

Du même auteur

The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases

Archive ouverte | Pagès, Mélanie | CCSD

International audience. Dysembryoplastic neuroepithelial tumour (DNT) is a glioneuronal tumour that is challenging to diagnose, with a wide spectrum of histological features. Three histopathological patterns have be...

Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma

Archive ouverte | Pagès, Mélanie | CCSD

International audience. Ganglioglioma (GG) is a grade I tumor characterized by alterations in the MAPK pathway, including BRAF V600E mutation. Recently, diffuse midline glioma with an H3 K27M mutation was added to t...

Deciphering the genetic and epigenetic landscape of pediatric bithalamic tumors

Archive ouverte | Tauziède-Espariat, Arnault | CCSD

International audience

Chargement des enrichissements...